# Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib

> **NCT05095649** · PHASE2 · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Graft vs Host Disease

## Interventions

- **BIOLOGICAL:** Regulatory T-cell enriched infusion

## Key facts

- **NCT ID:** NCT05095649
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-24
- **Primary completion:** 2025-08-15
- **Final completion:** 2026-02-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095649, "Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05095649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*